{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:15:37Z","timestamp":1791000937068,"version":"4.1.0"},"reference-count":55,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/or.2012.2133","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T13:17:09Z","timestamp":1352812629000},"page":"619-627","source":"Crossref","is-referenced-by-count":15,"title":["The antitumor effect of human cord blood-derived dendritic cells modified by the livin \u03b1 gene in lung cancer cell lines"],"prefix":"10.3892","volume":"29","author":[{"given":"HAO","family":"CHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YANG","family":"JIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINGQIANG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WANLI","family":"MA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANZHI","family":"XIONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAONAN","family":"TAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,11,13]]},"reference":[{"key":"key20180107214533_b1-or-29-02-0619","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.coi.2011.01.002","article-title":"Epidemiologic perspective on immune-surveillance in cancer","volume":"23","author":"Cramer","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"key20180107214533_b2-or-29-02-0619","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bcp.2010.04.010","article-title":"Apoptosis and cancer stem cells: implications for apoptosis targeted therapy","volume":"80","author":"Kruyt","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key20180107214533_b3-or-29-02-0619","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrm1621","article-title":"IAPs, RINGs and ubiquitylation","volume":"6","author":"Vaux","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107214533_b4-or-29-02-0619","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2012.01.060","article-title":"Sorafenib down-regulates c-IAP expression post-transcriptionally in hepatic carcinoma cells to suppress apoptosis","volume":"418","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107214533_b5-or-29-02-0619","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/cb900083m","article-title":"Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists","volume":"4","author":"Ndubaku","year":"2009","journal-title":"ACS Chem Biol"},{"key":"key20180107214533_b6-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-11-0218","article-title":"NF-kappaB is required for Smac mimetic-mediated sensitization of glioblastoma cells for gamma-irradiation-induced apoptosis","volume":"10","author":"Berger","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107214533_b7-or-29-02-0619","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0014-5793(01)02366-3","article-title":"Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern","volume":"495","author":"Ashhab","year":"2001","journal-title":"FEBS Lett"},{"key":"key20180107214533_b8-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.bjc.6604028","article-title":"Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney","volume":"97","author":"Wagener","year":"2007","journal-title":"Br J Cancer"},{"key":"key20180107214533_b9-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.leukres.2011.05.026","article-title":"Expression of inhibitor of apoptosis protein (IAP) livin\/BIRC7 in acute leukemia in adults: correlation with prognostic factors and outcome","volume":"35","author":"El-Mesallamy","year":"2011","journal-title":"Leuk Res"},{"key":"key20180107214533_b10-or-29-02-0619","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.critrevonc.2009.11.006","article-title":"Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer","volume":"75","author":"Stewart","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107214533_b11-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/1078-0432.1000.11.3","article-title":"Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin\/ML-IAP in lung cancer","volume":"11","author":"Hariu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107214533_b12-or-29-02-0619","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.humpath.2008.12.001","article-title":"Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance","volume":"40","author":"Chen","year":"2009","journal-title":"Hum Pathol"},{"key":"key20180107214533_b13-or-29-02-0619","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2009.06.002","article-title":"Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene","volume":"64","author":"Wang","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"key20180107214533_b14-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00018-007-6510-7","article-title":"Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis","volume":"64","author":"Crnkovic-Mertens","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"key20180107214533_b15-or-29-02-0619","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1038\/sj.onc.1206973","article-title":"Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin\/ML-IAP\/KIAP gene","volume":"22","author":"Crnkovic-Mertens","year":"2003","journal-title":"Oncogene"},{"key":"key20180107214533_b16-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1373\/49.7.1206","article-title":"Detection of anti-livin antibody in gastrointestinal cancer patients","volume":"49","author":"Yagihashi","year":"2003","journal-title":"Clin Chem"},{"key":"key20180107214533_b17-or-29-02-0619","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.lungcan.2004.11.002","article-title":"Detection of autoantibodies to livin and survivin in Sera from lung cancer patients","volume":"48","author":"Yagihashi","year":"2005","journal-title":"Lung Cancer"},{"key":"key20180107214533_b18-or-29-02-0619","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ccr.2012.01.008","article-title":"Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells","volume":"21","author":"Engelhardt","year":"2012","journal-title":"Cancer Cell"},{"key":"key20180107214533_b19-or-29-02-0619","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"key20180107214533_b20-or-29-02-0619","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ajh.22141","article-title":"Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia","volume":"86","author":"Atanackovic","year":"2011","journal-title":"Am J Hematol"},{"key":"key20180107214533_b21-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.molimm.2011.04.018","article-title":"Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells","volume":"48","author":"Seo","year":"2011","journal-title":"Mol Immunol"},{"key":"key20180107214533_b22-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2008.10.018","article-title":"Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer","volume":"65","author":"Kakimi","year":"2009","journal-title":"Lung Cancer"},{"key":"key20180107214533_b23-or-29-02-0619","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coi.2010.01.020","article-title":"Adoptive T cell therapy of cancer","volume":"22","author":"Brenner","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"key20180107214533_b24-or-29-02-0619","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.1995.tb08409.x","article-title":"Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation","volume":"89","author":"Han","year":"1995","journal-title":"Br J Haematol"},{"key":"key20180107214533_b25-or-29-02-0619","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jri.2010.02.002","article-title":"Cord blood as a source of non-senescent lymphocytes for tumor immunotherapy","volume":"85","author":"Germenis","year":"2010","journal-title":"J Reprod Immunol"},{"key":"key20180107214533_b26-or-29-02-0619","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clim.2008.02.008","article-title":"Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution","volume":"127","author":"Brown","year":"2008","journal-title":"Clin Immunol"},{"key":"key20180107214533_b27-or-29-02-0619","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"key20180107214533_b28-or-29-02-0619","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.lungcan.2009.07.007","article-title":"Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma","volume":"68","author":"Xie","year":"2010","journal-title":"Lung Cancer"},{"key":"key20180107214533_b29-or-29-02-0619","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-05-2013","article-title":"Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer","volume":"12","author":"Antonia","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107214533_b30-or-29-02-0619","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/j.vaccine.2007.05.030","article-title":"Plasmid DNA and viral vector-based vaccines for the treatment of cancer","volume":"25","author":"Anderson","year":"2007","journal-title":"Vaccine"},{"key":"key20180107214533_b31-or-29-02-0619","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri2073","article-title":"Prospects for the use of NK cells in immunotherapy of human cancer","volume":"7","author":"Ljunggren","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"key20180107214533_b32-or-29-02-0619","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","article-title":"Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection","volume":"65","author":"Guiducci","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107214533_b33-or-29-02-0619","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jim.2004.08.001","article-title":"Implication of delayed TNF-alpha exposure on dendritic cell maturation and expansion from cryopreserved cord blood CD34+ hematopoietic progenitors","volume":"293","author":"Xu","year":"2004","journal-title":"J Immunol Methods"},{"key":"key20180107214533_b34-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.vaccine.2009.01.017","article-title":"De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination","volume":"27","author":"Safdar","year":"2009","journal-title":"Vaccine"},{"key":"key20180107214533_b35-or-29-02-0619","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cellimm.2005.03.002","article-title":"Dexamethasone selectively inhibits differentiation of cord blood stem cell derived-dendritic cell (DC) precursors into immature DCs","volume":"232","author":"Mainali","year":"2004","journal-title":"Cell Immunol"},{"key":"key20180107214533_b36-or-29-02-0619","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0198-8859(03)00016-8","article-title":"Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T-Cell proliferation","volume":"64","author":"Gansuvd","year":"2003","journal-title":"Hum Immunol"},{"key":"key20180107214533_b37-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1158\/0008-5472.CAN-07-5965","article-title":"H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo","volume":"68","author":"Tang","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107214533_b38-or-29-02-0619","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trim.2008.07.006","article-title":"Porcine CFSE mixed lymphocyte reaction and PKH-26 cell-mediated lympholysis assays","volume":"20","author":"Oku","year":"2008","journal-title":"Transpl Immunol"},{"key":"key20180107214533_b39-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.intimp.2011.04.002","article-title":"Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity","volume":"11","author":"Luo","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"key20180107214533_b40-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.tiv.2011.09.001","article-title":"Cantharidin modulates development of human monocyte-derived dendritic cells","volume":"25","author":"Hsieh","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"key20180107214533_b41-or-29-02-0619","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.imbio.2008.02.006","article-title":"Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays","volume":"213","author":"Cholujova","year":"2008","journal-title":"Immunobiology"},{"key":"key20180107214533_b42-or-29-02-0619","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)60404-9","article-title":"Use of tumour-responsive T cells as cancer treatment","volume":"373","author":"Disis","year":"2009","journal-title":"Lancet"},{"key":"key20180107214533_b43-or-29-02-0619","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.4049\/jimmunol.168.7.3484","article-title":"Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin","volume":"168","author":"Seki","year":"2002","journal-title":"J Immunol"},{"key":"key20180107214533_b44-or-29-02-0619","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.4049\/jimmunol.171.5.2402","article-title":"The Fas\/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases","volume":"171","author":"Caldwell","year":"2003","journal-title":"J Immunol"},{"key":"key20180107214533_b45-or-29-02-0619","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1158\/1078-0432.CCR-07-4804","article-title":"Targeted therapies to improve tumor immunotherapy","volume":"14","author":"Begley","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107214533_b46-or-29-02-0619","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-2478(00)00324-2","article-title":"The response of human dendritic cells to recombinant adenovirus, recombinant Mycobacterium bovis Bacillus Calmette Guerin and biolistic methods of antigen delivery: different induction of contact-dependant and soluble signals","volume":"76","author":"Smith","year":"2001","journal-title":"Immunol Lett"},{"key":"key20180107214533_b47-or-29-02-0619","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-3-17","article-title":"Adoptive T cell therapy: addressing challenges in cancer immunotherapy","volume":"3","author":"Yee","year":"2005","journal-title":"J Transl Med"},{"key":"key20180107214533_b48-or-29-02-0619","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cellimm.2008.08.004","article-title":"The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK\/GCV induced dying cells","volume":"254","author":"Xing","year":"2009","journal-title":"Cell Immunol"},{"key":"key20180107214533_b49-or-29-02-0619","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00005-011-0157-7","article-title":"Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report","volume":"60","author":"Wojas-Krawczyk","year":"2012","journal-title":"Arch Immunol Ther Exp"},{"key":"key20180107214533_b50-or-29-02-0619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2010.07.002","article-title":"Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy","volume":"7","author":"Prasad","year":"2011","journal-title":"Nanomedicine"},{"key":"key20180107214533_b51-or-29-02-0619","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.smim.2008.02.001","article-title":"About human tumor antigens to be used in immunotherapy","volume":"20","author":"Lucas","year":"2008","journal-title":"Semin Immunol"},{"key":"key20180107214533_b52-or-29-02-0619","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4161\/hv.4.3.5291","article-title":"Formulation and characterization of a ten-peptide single-vial vaccine, EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy","volume":"4","author":"Beebe","year":"2008","journal-title":"Hum Vaccin"},{"key":"key20180107214533_b53-or-29-02-0619","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.coi.2003.09.018","article-title":"Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation","volume":"15","author":"Spiotto","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"key20180107214533_b54-or-29-02-0619","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cellimm.2006.06.005","article-title":"Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses","volume":"240","author":"Yang","year":"2006","journal-title":"Cell Immunol"},{"key":"key20180107214533_b55-or-29-02-0619","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/S0024-3205(03)00196-6","article-title":"Role of inherited defects decreasing Fas function in autoimmunity","volume":"72","author":"Dianzani","year":"2003","journal-title":"Life Sci"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2133\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T19:32:35Z","timestamp":1687807955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,13]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,11,13]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/or.2012.2133"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2133","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,13]]}}}